Chris Morten is a lawyer who currently teaches at New York University School of Law, as the Deputy Director of NYU’s Technology Law and Policy Clinic. He is also a Fellow at NYU’s Engelberg Center on Innovation Law & Policy.
Chris’s clinical work, research, and writing focus on access to knowledge, with particular emphasis on health justice. Much of his work seeks to expand access to medicines and access to information about medicines. His current projects include
- representation of an HIV/AIDS advocacy group in its efforts to expand access to HIV and COVID-19 medicines;
- litigation under the Freedom of Information Act that seeks clinical trial data on a controversial prescription drug and addresses the proper scope of information that may be withheld by federal agencies as trade secrets and “confidential commercial information”;
- academic research on the Food and Drug Administration’s authority to proactively disclose information important to public health and safety; and
- academic research on the nature of patent rights.
Before returning to NYU, Chris worked at Yale Law School, where he was Staff Attorney and Research Scholar in Law at the Collaboration for Research Integrity and Transparency and Supervising Attorney and Clinical Lecturer in Law at Yale Law School’s Media Freedom & Information Access Clinic. Chris remains a Visiting Fellow of the Global Health Justice Partnership and an Affiliated Fellow of the Information Society Project at Yale Law School. Before Yale, Chris worked as a litigation associate and science advisor at Goodwin Procter L.L.P. and as a patent agent at Baker Botts L.L.P. He clerked for the Honorable Timothy B. Dyk of the U.S. Court of Appeals for the Federal Circuit from 2015 to 2016.
Chris received his J.D., magna cum laude and Order of the Coif, from New York University, a Ph.D. in organic chemistry from the Massachusetts Institute of Technology, and a B.A. in chemistry, summa cum laude, from Columbia University. In his graduate research in the Jamison Group at MIT, Chris investigated the biomimetic synthesis of a class of natural products known as the ladder polyethers.